The transformative role of artificial intelligence (AI) in clinical research and the ways AI technologies are already being integrated across every stage of the clinical trial process were the focus of a presentation delivered by HACRO President Evangelia (Lia) Koraki during the panel discussion “AI Applications in Healthcare” at the 3rd Market Access for non-Market Access Conference, organised by the Hellenic Market Access Association (ELEMA) on 28 May.
AI is already reshaping the clinical research landscape by enabling intelligent automation, supporting more informed decision-making and helping address complex operational and scientific challenges. Rather than replacing researchers or healthcare professionals, AI serves as a powerful tool that enhances their expertise and strengthens the clinical research process.
When applied responsibly, transparently and ethically, AI has the potential to become a key driver of innovation, accelerating the development of new therapies and enabling faster, safer access to innovative treatments for patients.